When comparing strategies for manipulating RIPK1, direct activation of RIPK1 through the loss of checkpoint kinases such as TBK1/IKKε may exhibit higher efficiency in tumor killing than knockout strategies, such as RIPK1 KO or PROTAC-mediated degradation, which eliminate the protein entirely. This evidence concerns the gene RIPK1 and neoplasm.